190 related articles for article (PubMed ID: 31921643)
21. Identifying optimal surgical approach among T1N2-3M0 non-small cell lung cancer patients: a population-based analysis.
Ge T; Hu SQ; Ning J; Zhou YF; Bian DL; Teng MX; Chen LS; Yang J
Transl Lung Cancer Res; 2024 Apr; 13(4):901-929. PubMed ID: 38736488
[TBL] [Abstract][Full Text] [Related]
22. Development and validation of a nomogram for predicting survival time and making treatment decisions for clinical stage IA NSCLC based on the SEER database.
Xu B; Ye Z; Zhu L; Xu C; Lu M; Wang Q; Yao W; Zhu Z
Front Med (Lausanne); 2022; 9():972879. PubMed ID: 36619647
[TBL] [Abstract][Full Text] [Related]
23. A Nomogram for Prediction of Overall Survival in Patients with Node-negative Gallbladder Cancer.
Chen M; Cao J; Zhang B; Pan L; Cai X
J Cancer; 2019; 10(14):3246-3252. PubMed ID: 31289596
[No Abstract] [Full Text] [Related]
24. Prognostic Significance of Tumor Deposits in Patients With Stage III Colon Cancer: A Nomogram Study.
Zheng P; Chen Q; Li J; Jin C; Kang L; Chen D
J Surg Res; 2020 Jan; 245():475-482. PubMed ID: 31446189
[TBL] [Abstract][Full Text] [Related]
25. [Risk factor analysis on anastomotic leakage after laparoscopic surgery in rectal cancer patient with neoadjuvant therapy and establishment of a nomogram prediction model].
Jiang W; Feng MY; Dong XY; Dong SM; Zheng JX; Liu XM; Liu WJ; Yan J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):748-754. PubMed ID: 31422613
[No Abstract] [Full Text] [Related]
26. Development and validation of two prognostic nomograms for predicting survival in patients with non-small cell and small cell lung cancer.
Xiao HF; Zhang BH; Liao XZ; Yan SP; Zhu SL; Zhou F; Zhou YK
Oncotarget; 2017 Sep; 8(38):64303-64316. PubMed ID: 28969072
[TBL] [Abstract][Full Text] [Related]
27. Development and validation of nomogram combining serum biomarker for predicting survival in patients with resected rectal cancer.
Fan S; Li T; Zhou P; Peng Q; Zhu Y
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693739
[TBL] [Abstract][Full Text] [Related]
28. Clinical features and prognostic factors of combined small cell lung cancer: development and validation of a nomogram based on the SEER database.
Yang L; Zhou Y; Wang G; Liu D; Chen B; Pu D; Correale P; Rades D; Tomita Y; Inno A; Santarpia M; Li Y; Li W
Transl Lung Cancer Res; 2021 Nov; 10(11):4250-4265. PubMed ID: 35004254
[TBL] [Abstract][Full Text] [Related]
29. Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc.
Cui J; Jiang H
Medicine (Baltimore); 2019 Oct; 98(40):e17370. PubMed ID: 31577739
[TBL] [Abstract][Full Text] [Related]
30. A nomogram for the prediction of overall survival in patients with stage II and III non-small cell lung cancer using a population-based study.
Liao Y; Wang X; Zhong P; Yin G; Fan X; Huang C
Oncol Lett; 2019 Dec; 18(6):5905-5916. PubMed ID: 31788064
[TBL] [Abstract][Full Text] [Related]
31. Nomogram prediction for the survival of the patients with small cell lung cancer.
Pan H; Shi X; Xiao D; He J; Zhang Y; Liang W; Zhao Z; Guo Z; Zou X; Zhang J; He J
J Thorac Dis; 2017 Mar; 9(3):507-518. PubMed ID: 28449457
[TBL] [Abstract][Full Text] [Related]
32. A validated nomogram integrating baseline peripheral T-lymphocyte subsets and NK cells for predicting survival in stage I-IIIA non-small cell lung cancer after resection.
Xu L; Luo Y; Tian J; Fang Z; Zhu W; Zhang B; Wu J; Li Y
Ann Transl Med; 2022 Mar; 10(5):250. PubMed ID: 35402593
[TBL] [Abstract][Full Text] [Related]
33. Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy.
Wang CY; Yang J; Zi H; Zheng ZL; Li BH; Wang Y; Ge Z; Jian GX; Lyu J; Li XD; Ren XQ
BMC Cancer; 2020 Jan; 20(1):10. PubMed ID: 31906882
[TBL] [Abstract][Full Text] [Related]
34. A clinical risk model for assessing the survival of patients with stage IA-IIA non-small cell lung cancer after surgery.
Qian JY; Li ZX; Wu LL; Song SH; Li CW; Lin WK; Xu SQ; Li K; Xie D
J Thorac Dis; 2022 Nov; 14(11):4285-4296. PubMed ID: 36524081
[TBL] [Abstract][Full Text] [Related]
35. Construction of a nomogram predicting the overall survival of patients with distantly metastatic non-small-cell lung cancer.
Deng J; Ren Z; Wen J; Wang B; Hou X; Xue Z; Chu X
Cancer Manag Res; 2018; 10():6143-6156. PubMed ID: 30538562
[TBL] [Abstract][Full Text] [Related]
36. A Nomogram to Predict Long-Term Survival Outcomes of Patients Who Undergo Pneumonectomy for Non-small Cell Lung Cancer With Stage I-IIIB.
Wu LL; Chen WT; Liu X; Jiang WM; Huang YY; Lin P; Long H; Zhang LJ; Ma GW
Front Surg; 2021; 8():604880. PubMed ID: 33996882
[No Abstract] [Full Text] [Related]
37. A Prediction Rule for Overall Survival in Non-Small-Cell Lung Cancer Patients with a Pathological Tumor Size Less Than 30 mm.
Zhu WY; Fang KX; He JY; Cui R; Zhang YK; Le HB
Dis Markers; 2019; 2019():8435893. PubMed ID: 31191756
[TBL] [Abstract][Full Text] [Related]
38. A Novel Nomogram for Predicting the Survival of Patients with Invasive Upper Tract Urothelial Carcinoma.
Li Z; Li X; Li Y; Liu Y; Du P; Liu Z; Xiao K
J Cancer; 2021; 12(3):790-798. PubMed ID: 33403036
[No Abstract] [Full Text] [Related]
39. Identification of Resectable N2 in NSCLC: A Single Center Experience and Review of the SEER Database.
Wang YQ; Liu XD; Bai WL; Li SQ
Front Oncol; 2021; 11():647546. PubMed ID: 33981606
[TBL] [Abstract][Full Text] [Related]
40. Development and external validation of a nomogram for predicting the effect of tumor size on cancer-specific survival of resected gallbladder cancer: a population-based study.
Zhang Y; Zhou T; Han S; Chang J; Jiang W; Wang Z; Li C; Li X
Int J Clin Oncol; 2021 Jun; 26(6):1120-1129. PubMed ID: 33666788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
